Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
282
datasets available to search
ShareScore release 0.9.0
Dataset results
282 results for “disease diagnostics”
Diagnostic Value of the Electrocardiogram in Fabry Disease
ClinicalTrials.gov study NCT03362645. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Gastroesophageal Reflux Disease Diagnostic Trial
ClinicalTrials.gov study NCT06504134. IPD Sharing: NO. Countries: 0. Publications: 0.
Diagnostic Values of C-reactive Protein and Procalcitonin in Predicting Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT03923803. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Percutaneos Liver Biopsy in Pediatric Patient : Diagnostic Significance and Pattern of Liver Diseases
ClinicalTrials.gov study NCT06773390. IPD Sharing: NO. Countries: 0. Publications: 0.
Novel Diagnostic and Prognostic Predictors in Fabry Cardiomyopathy: Proof of Concept in a Rare Disease
ClinicalTrials.gov study NCT07351136. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Diagnostic Study for Differentiating Functional From Organic Diseases in Patients With Lower GIT Symptoms
ClinicalTrials.gov study NCT07016529. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers
ClinicalTrials.gov study NCT01442350. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701)
ClinicalTrials.gov study NCT01381666. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Contribution of New Generation Oxford Nanopore-type High-throughput Sequencing in the Diagnostic Strategy of Neurogenetic Diseases.
ClinicalTrials.gov study NCT04621422. IPD Sharing: NO. Countries: 0. Publications: 0.
Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients
ClinicalTrials.gov study NCT06654076. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Diagnostic Value of Serum Oncostatin M and Galactin 3 as Biomarkers in Diagnosis of Ulcerative Colitis Disease
ClinicalTrials.gov study NCT06959654. IPD Sharing: YES. Countries: 0. Publications: 0.
The Evaluation of Pro/Antioxidative Profile and Diagnostic Parameters in the Patients With Pancreatic Disease
ClinicalTrials.gov study NCT03028181. IPD Sharing: NO. Countries: 0. Publications: 0.
Diagnostic Value of Chest Ultrasound in Pediatrics Lung Diseases
ClinicalTrials.gov study NCT04326972. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Soluble Programmed Death 1 (sPD1) is a Diagnostic Biomarker of ILD in Patients With Rheumatoid Arthritis Disease
ClinicalTrials.gov study NCT05105230. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Diagnostic Classifier for Gene Expression-Based Identification of Early Lyme Disease
GEO Series GSE196192. Homo sapiens. 31 samples. Type: Expression profiling by high throughput sequencing.
The use of plasma microRNAs (miRs) as diagnostic and prognostic biomarkers of chronic kidney disease (CKD)
GEO Series GSE262414. Homo sapiens. 33 samples. Type: Non-coding RNA profiling by high throughput sequencing.
Dataset related to article "Digital single-operator cholangioscopy in diagnostic and therapeutic bilio-pancreatic diseases: A prospective, multicenter study "
<p>This record contains raw data related to article “Digital single-operator cholangioscopy in diagnostic and therapeutic bilio-pancreatic diseases: A prospective, multicenter study"</p> <p><strong>Background and aim: </strong> Digital single-operator cholangioscopy (D-SOC) is an endoscopic procedure that is increasingly used for the management of bilio-pancreatic diseases. We aimed to investigate the efficacy and safety of D-SOC for diagnostic and therapeutic indications.</p> <p><strong>Methods: </strong> This is a multicenter, prospective study(January 2016-June 2019) across eighteen tertiary centers. The primary outcome was procedural success of D-SOC. Secondary outcomes were: D-SOC visual assessment and diagnostic yield of SpyBite biopsy in cases of biliary strictures, stone clearance rate in cases of difficult biliary stones, rate of adverse events(AEs) for all indications.</p> <p><strong>Results: </strong> D-SOC was performed in 369 patients (201(54,5%) diagnostic and 168(45,5%)therapeutic). Overall, procedural success rate was achieved in 360(97,6%) patients. The sensitivity, specificity, PPV, NPV and accuracy in biliary strictures were: 88,5%, 77,3%, 83,3%, 84,1% and 83,6% for D-SOC visual impression; 80,2%, 92,6%, 95,1%, 72,5% and 84,7% for the SpyBite biopsy, respectively. For difficult biliary stones, complete duct clearance was obtained in 92,1% patients (82,1% in a single session). Overall, AEs occurred in 37(10%) cases.The grade of AEs was mild or moderate for all cases, except one which was fatal.</p> <p><strong>Conclusion: </strong> D-SOC is effective for diagnostic and therapeutic indications.Most of the AEs were minor and managed conservatively, even though a fatal event has happened that is not negligible and should be considered before using D-SOC.</p>
ECRG4 as a novel diagnostic plasma marker detected in the early phase of Alzheimer’s disease
GEO Series GSE299804. Homo sapiens. 2 samples. Type: Expression profiling by high throughput sequencing.
Dataset related to the article "Diagnostic accuracy of subendocardial vs. transmural myocardial perfusion defect for the detection of in-stent restenosis or progression of coronary artery disease after percutaneous coronary intervention
<p>This record contains raw datarelated to the article"Diagnostic accuracy of subendocardial vs. transmural myocardial perfusion defect for the detection of in-stent restenosis or progression of coronary artery disease after percutaneous coronary intervention</p> <p> </p> <p>Background. The ADVANTAGE study demonstrated in a cohort of stented patients a diagnostic accuracy of stress myocardial CT perfusion (CTP) significantly higher than that of coronary CT angiography (CCTA) for the detection of in-stent restenosis (ISR) or CAD progression vs. quantitative coronary angiography (QCA). This is a pre-defined subanalysis of the ADVANTAGE aimed at assessing the difference in terms of diagnostic accuracy vs. QCA of a subendocardial vs. a transmural perfusion defect using static stress CTP.<br> Methods. We enrolled consecutive patients who previously underwent coronary stenting and were referred for QCA. All patients underwent stress CTP and rest CTP+CCTA. The diagnostic accuracy of CCTA and CTP were evaluated in territory-based and patient-based analyses. We compared the diagnostic accuracy of “subendocardial” perfusion defect, defined as hypo-enhancement encompassing >25% but <50% of the transmural myocardial thickness within a specific coronary territory vs. “transmural” perfusion defect, defined as hypo-enhancement encompassing >50% of the transmural thickness.<br> Results. In 150 patients (132 men, mean age 65.1±9.1 years), the diagnostic accuracy of subendocardial vs. transmural perfusion defect in a vessel-based analysis was 93.5% vs. 87.7%, respectively (p<0.0001). The sensitivity and specificity of subendocardial vs. transmural defect were 87.9% vs. 46.9% (p<0.001) and 94.9% vs. 97.9% (p=0.004), respectively. In a patient-based analysis, the diagnostic accuracy of the subendocardial vs. transmural approach was 86.6% vs. 68% (p<0.0001).<br> Conclusions. This study shows that detection of a subendocardial perfusion defect as compared to a transmural defect is significantly more accurate to identify coronary territories with ISR or CAD progression.</p> <p> </p>
DNA methylation markers in peripheral blood as effective diagnostic biomarkers for adult-onset Still’s disease
GEO Series GSE229738. Homo sapiens. 172 samples. Type: Methylation profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.